Impacts of hypervirulence determinants on clinical features and outcomes of bacteremia caused by extended-spectrum β-lactamase-producing klebsiella pneumoniae

Microbial Drug Resistance

Volumn 23, Issue 3, 2017, Pages 376-383

  Yu, Wen Liang ^a,b   Lee, Mei Feng ^a   Chen, Chi Chung ^a   Tang, Hung Jen ^a,c   Ho, Chung Han ^a   Chuang, Yin Ching ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

ESBL; hypermucoviscosity; hypervirulence; Klebsiella pneumoniae; rmpA; virulence

Indexed keywords

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTERIAL CAPSULE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHARLSON COMORBIDITY INDEX; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DIABETIC PATIENT; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HOSPITAL INFECTION; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; LIVER ABSCESS; MALE; MORBIDITY; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ABSCESS; PERIANAL ABSCESS; PHENOTYPE; PRIMARY INFECTION; PRIORITY JOURNAL; SECONDARY INFECTION; URINARY TRACT INFECTION; BACTEREMIA; CROSS INFECTION; GENETICS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; MIDDLE AGED; SEROTYPE; URINARY TRACT INFECTIONS;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; VIRULENCE FACTOR;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; SEROGROUP; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 85017170660     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2016.0018     Document Type: Article

References (36)

1. Yu, W.L., W.C. Ko, K.C. Cheng, H.C. Lee, D.S. Ke, C.C. Lee, C.P. Fung, and Y.C. Chuang. 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 42:1351-1358.
2. Ku, Y.H., Y.C. Chuang, and W.L. Yu. 2008. Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-Acquired extrahepatic abscess. J. Microbiol. Immunol. Infect. 41:311-317.
3. Tseng, C.P., H.S. Wu, T.H. Wu, Y.T. Lin, and C.P. Fung. 2013. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care. J. Microbiol. Immunol. Infect. 46:217-223.
4. Su, S.C., L.K. Siu, L. Ma, K.M. Yeh, C.P. Fung, J.C. Lin, and F.Y. Chang. 2008. Community-Acquired liver abscess caused by serotype K1 Klebsiella pneumoniae with CTXM-15-Type extended-spectrum b-lactamase. Antimicrob. Agents Chemother. 52:804-805.
5. Yoon, J.H., Y.J. Kim, Y.H. Jun, S.I. Kim, J.Y. Kang, K.T. Suk, and D.J. Kim. 2014. Liver abscess due to Klebsiella pneumoniae: risk factors for metastatic infection. Scand. J. Infect. Dis. 46:21-26.
6. Lee, N.Y., C.C. Lee, W.H. Huang, K.C. Tsui, P.R. Hsueh, and W.C. Ko. 2012. Carbapenem therapy for bacteremia due to extended-spectrum-b-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility. Antimicrob. Agents Chemother. 56:2888-2893.
7. Yang, C.C., S.H. Li, F.R. Chuang, C.H. Chen, C.H. Lee, J.B. Chen, C.H. Wu, and C.T. Lee. 2012. Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum b-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis. BMC Infect. Dis. 12:206.
8. Fang, C.T., Y.P. Chuang, C.T. Shun, S.C. Chang, and J.T. Wang. 2004. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med. 199:697-705.
9. Fang, C.T, S.Y. Lai, W.C. Yi, P.R. Hsueh, K.L. Liu, and S.C. Chang. 2007. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin. Infect. Dis. 45:284-293.
10. Yu, V.L., D.S. Hansen, W.C. Ko, A. Sagnimeni, K.P. Klugman, A. von Gottberg, H. Goossens, M.M. Wagener, V.J., and Benedi and International Klebseilla Study Group. 2007. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg. Infect. Dis. 13:986-993.
11. Yu, W.L., W.C. Ko, K.C. Cheng, C.C. Lee, C.C. Lai, and Y.C. Chuang. 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn. Microbiol. Infect. Dis. 62:1-6.
12. Cheng, H.Y., Y.S. Chen, C.Y. Wu, H.Y. Chang, Y.C. Lai, and H.L. Peng. 2010. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J. Bacteriol. 192:3144-3158.
13. Hsu, C.R., T.L. Lin, Y.C. Chen, H.C. Chou, and J.T. Wang. 2011. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited. Microbiology. 157:3446-3457.
14. Wacharotayankun, R., Y. Arakawa, M. Ohta, K. Tanaka, T. Akashi, M. Mori, and N. Kato. 1993. Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect. Immun. 61:3164-3174.
15. Lai, Y.C., H.L. Peng, and H.Y. Chang. 2003. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J. Bacteriol. 185:788-800.
16. Lin, Y.T., Y.Y. Jeng, T.L. Chen, and C.P. Fung. 2010. Bacteremic community-Acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect. Dis. 10:307.
17. Li, W., G. Sun, Y. Yu, N. Li, M. Chen, R. Jin, Y. Jiao, and H. Wu. 2014. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin. Infect. Dis. 58:225-232.
18. Yu, W.L., M.F. Lee, H.J. Tang, M.C. Chang, and Y.C. Chuang YC. 2015. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum b-lactamase-producing Klebsiella pneumoniae isolates. Virulence. 6:162-172.
19. Charlson, M.E., P. Pompei, K.L. Ales, and C.R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
20. Knaus, W.A., E.A. Draper, D.P. Wagner, and J.E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829.
21. ARDS Definition Task Force, V.M. Ranieri, G.D. Rubenfeld, B.T. Thompson, N.D. Ferguson, E. Caldwell, E. Fan, L. Camporota, and A.S. Slutsky. 2012. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 307:2526-2533.
22. Clinical and Laboratory Standards Institute. 2010. Performance Standards for Antimicrobial Susceptibility Testing: CLSI M100-S20. Clinical and Laboratory Standards Institute Press, Wayne, PA.
23. Cheng, N.C., Y.C. Yu, H.C. Tai, P.R. Hsueh, S.C. Chang, S.Y. Lai, W.C. Yi, and C.T. Fang. 2012. Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin. Infect. Dis. 55:930-939.
24. Yeh, K.M., J.C. Lin, F.Y. Yin, C.P. Fung, H.C. Hung, L.K. Siu, and F.Y. Chang. 2010. Revisiting the importance of virulence determinant magA and its surrounding genes in Klebsiella pneumoniae causing pyogenic liver abscesses: exact role in serotype K1 capsule formation. J. Infect. Dis. 201:1259-1267.
25. Yu, W.L., C.P. Fung, W.C. Ko, K.C. Cheng, C.C. Lee, and Y.C. Chuang. 2007. Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites. J. Infect. Dis. 195:1235-1236.
26. Boratyn, G.M., C. Camacho, P.S. Cooper, G Coulouris, A. Fong, N Ma, T.L. Madden, W.T. Matten, S.D. McGinnis, Y. Merezhuk, Y. Raytselis, E.W. Sayers, T. Tao, J. Ye, and I. Zaretskaya. 2013. BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 41(Web Server issue):W29-W33.
27. Lee, C.H., J.W. Liu, L.H. Su, C.C. Chien, C.C. Li, and K.D. Yang. 2010. Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: a prospective cross-sectional study in Taiwan. Int. J. Infect. Dis. 14:e688-e692.
28. Wu, H.S., F.D. Wang, C.P. Tseng, T.H. Wu, Y.T. Lin, and C.P. Fung. 2012. Characteristics of healthcare-Associated and community-Acquired Klebsiella pneumoniae bacteremia in Taiwan. J. Infect. 64:162-168.
29. Lin, J.C., F.Y. Chang, C.P. Fung, J.Z. Xu, H.P. Cheng, J.J. Wang, L.Y. Huang, and L. K. Siu. 2004. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect. 6:1191-1198.
30. Yu, W.L., K.S. Chan, W.C. Ko, C.C. Lee, and Y.C. Chuang. 2007. Lower prevalence of diabetes mellitus in patients with Klebsiella pneumoniae primary liver abscess caused by isolates of K1/K2 than with non-K1/K2 capsular serotypes. Clin. Infect. Dis. 45:1529-1530.
31. Lee, C.H., L.H. Su, Y.F. Tang, and J.W. Liu. 2006. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates. J. Antimicrob. Chemother. 58:1074-1077.
32. Liu, Y.M., B.B. Li, Y.Y. Zhang, W. Zhang, H. Shen, H. Li, and B. Cao. 2014. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob. Agents Chemother. 58:5379-5385.
33. De Rosa, F.G., N. Pagani, L. Fossati, S. Raviolo, C. Cometto, P. Cavallerio, C. Parlato, E. Guglielmi, R. Serra, and G. Di Perri. 2011. The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection. 39:555-561.
34. Tamma, P.D., J.H. Han, C. Rock, A.D. Harris, E. Lautenbach, A.J. Hsu, E. Avdic, S.E. Cosgrove, and Antibacterial Resistance Leadership Group. 2015. Carbapenem therapy is associated with improved survival compared with piperacillin-Tazobactam for patients with extended-spectrum b-lactamase bacteremia. Clin. Infect. Dis. 60:1319-1325.
35. Shon, A.S., R.P. Bajwa, and T.A. Russo. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 4:107-118.
36. Qu, T., J. Zhou, Y. Jiang, K.R. Shi, B. Li, P. Shen, Z.Q. Wei, and Y.S. Yu. 2015. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China. BMC Infect. Dis.15:161.